(NASDAQ:SPPI) LOS ANGELES, Sept. 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. ("Spectrum" or "the Company") (NASDAQ: SPPI) for violations of §§10(b) and 20(a) of the...
Related Questions
How likely is a settlement or judgment, and what magnitude of potential liability could affect SPPI's valuation?
What is the expected timeline for the lawsuit's progression and any potential impact on upcoming earnings or financing activities?
Are there observable changes in insider or institutional trading patterns following the filing that could signal market sentiment?